WO2012081038A3 - Anticancer compounds and targeting cancer with the same - Google Patents

Anticancer compounds and targeting cancer with the same Download PDF

Info

Publication number
WO2012081038A3
WO2012081038A3 PCT/IN2011/000865 IN2011000865W WO2012081038A3 WO 2012081038 A3 WO2012081038 A3 WO 2012081038A3 IN 2011000865 W IN2011000865 W IN 2011000865W WO 2012081038 A3 WO2012081038 A3 WO 2012081038A3
Authority
WO
WIPO (PCT)
Prior art keywords
pharmaceutically acceptable
same
cancer cells
cancer
targeting cancer
Prior art date
Application number
PCT/IN2011/000865
Other languages
French (fr)
Other versions
WO2012081038A2 (en
Inventor
Martin Annette
Shruti Patil
Nilesh Shridhar Malik
Kailash Dattatraya Panghavane
Original Assignee
Godavari Biorefineries Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Godavari Biorefineries Limited filed Critical Godavari Biorefineries Limited
Publication of WO2012081038A2 publication Critical patent/WO2012081038A2/en
Publication of WO2012081038A3 publication Critical patent/WO2012081038A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention provides compounds having the general formula I or pharmaceutically acceptable salt thereof, and pharmaceutically acceptable compositions having ability to inhibit proliferation of and/or eradicate cancer cells and/or cancer cells having significant self-renewal potential, such as cancer stem cells (CSCs). Such compounds have the general formula I. The invention also provides the use of a compound of formula I, or a pharmaceutically acceptable salt thereof, or pharmaceutically acceptable compositions thereof in inhibiting the proliferation of and/or eradicating cancer cells and/or cancer cells having significant self-renewal potential, such as cancer stem cells (CSCs).
PCT/IN2011/000865 2010-12-17 2011-12-16 Anticancer compounds and targeting cancer with the same WO2012081038A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN3241MU2010 2010-12-17
IN3241/MUM/2010 2010-12-17

Publications (2)

Publication Number Publication Date
WO2012081038A2 WO2012081038A2 (en) 2012-06-21
WO2012081038A3 true WO2012081038A3 (en) 2016-05-26

Family

ID=46245172

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2011/000865 WO2012081038A2 (en) 2010-12-17 2011-12-16 Anticancer compounds and targeting cancer with the same

Country Status (1)

Country Link
WO (1) WO2012081038A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7198221B2 (en) 2017-04-20 2022-12-28 ゴーダーヴァリ バイオリファイナリーズ リミテッド anticancer compounds

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013365649A1 (en) * 2012-12-18 2015-07-30 Godavari Biorefineries Limited Agents for eliminating tumour-initiating cells
CN113365615A (en) * 2018-12-17 2021-09-07 戈达瓦里生物炼制有限责任公司 Compounds for inhibiting unregulated cell growth

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4486445A (en) * 1983-01-12 1984-12-04 E. I. Du Pont De Nemours And Company Justicidin insecticidal and antiviral compounds
US20080187595A1 (en) * 2005-08-19 2008-08-07 Andreas Jordan Method For Carrying Therapeutic Substances Into Cells
US20090202662A1 (en) * 2006-05-25 2009-08-13 Csir Treatment of erectile dysfunction and libido enhancement

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4486445A (en) * 1983-01-12 1984-12-04 E. I. Du Pont De Nemours And Company Justicidin insecticidal and antiviral compounds
US20080187595A1 (en) * 2005-08-19 2008-08-07 Andreas Jordan Method For Carrying Therapeutic Substances Into Cells
US20090202662A1 (en) * 2006-05-25 2009-08-13 Csir Treatment of erectile dysfunction and libido enhancement

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7198221B2 (en) 2017-04-20 2022-12-28 ゴーダーヴァリ バイオリファイナリーズ リミテッド anticancer compounds

Also Published As

Publication number Publication date
WO2012081038A2 (en) 2012-06-21

Similar Documents

Publication Publication Date Title
TN2012000413A1 (en) Pyrrolopyrimidine compounds as inhibitors of cdk4/6
CA2871471C (en) Dna-pk inhibitors
IN2014CN04530A (en)
WO2012068234A3 (en) Antiviral compounds
IN2014MN02497A (en)
MX2013001970A (en) Pyrrolopyrimidine compounds and uses thereof.
MA33803B1 (en) BENZODIAZEPINE BROMODOMAINE INHIBITOR
EA201201159A1 (en) DETERATED PYRROPOLYMIDININE COMPOUNDS AS CDK4 / 6 INHIBITORS
UA110943C2 (en) N-acyl sulfonamideapoptosis promoters
IN2012DN01233A (en)
WO2012046030A3 (en) Phosphodiesterase inhibitors
MX2013006802A (en) Neprilysin inhibitors.
TN2014000016A1 (en) 4 - piperidinyl compounds for use as tankyrase inhibitors
MX2011012739A (en) Fluorinated aminotriazole derivatives.
WO2011039735A3 (en) Compounds with ddx3 inhibitory activity and uses thereof
MX2013004162A (en) Pharmaceutical compositions containing a dgat1 inhibitor.
WO2010150211A3 (en) Use of derivatives of indoles for the treatment of cancer
NZ596628A (en) Ketolide compounds having antimicrobial activity
MX2014013851A (en) Topical pharmaceutical compositions comprising terbinafine and urea.
WO2012162513A3 (en) Alcohol-, diol-, and carbohydrate-substituted indenoisoquinolines as topoisomerase i inhibitors
MX2009008028A (en) Benzofuran antiparasitic agents.
TN2012000105A1 (en) Spirolactam derivatives and uses of same
WO2010089327A3 (en) Indole derivatives as anticancer agents
MX2013002620A (en) Novel n-hydroxy-benzamides for the treatment of cancer.
WO2010076009A8 (en) Pyrimidine derivatives and the use thereof for combating undesired plant growth

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11848090

Country of ref document: EP

Kind code of ref document: A2